Cargando…
Role and mechanism of action of LRIG1 in ovarian cancer cell line and VP16 drug-resistant cell line
We investigated the role of leucine-rich repeats and immunoglobulin-like domains (LRIG)-1 in ovarian cancer cell line and VP16 drug-resistant cell line to explore the possible mechanism of action. Human ovarian cancer cell line SKOV3 and the VP16 drug-resistant cell line SKOV3/VP16 were used to inve...
Autores principales: | Zhang, Yaqi, Liu, Zhizhen, Yu, Shunrui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592861/ https://www.ncbi.nlm.nih.gov/pubmed/28943962 http://dx.doi.org/10.3892/ol.2017.6730 |
Ejemplares similares
-
Establishment and Characterization of Resistant Cells to Etoposide (VP16) from a Mouse Breast Cancer Cell Line, FM3A
por: Takagi, Eishi, et al.
Publicado: (1988) -
Hypophosphorylation of Topoisomerase IIα in Etoposide (VP‐16)‐resistant Human Carcinoma Cell Lines Associated with Carboxy‐terminal Truncation
por: Matsumoto, Yoshihito, et al.
Publicado: (2001) -
The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma
por: Cheng, Fangling, et al.
Publicado: (2019) -
Expression of Drug Resistance Genes in VP‐16 and mAMSA‐selected Human Carcinoma Cells
por: Matsumoto, Yoshihito, et al.
Publicado: (2001) -
LRIG and cancer prognosis
por: Lindquist, David, et al.
Publicado: (2014)